MAPT and Alzheimer disease: An increased conversion of p35 into p25 has been linked to the activation of Cdk5 and hyperphosphorylation of tau in both ex vivo and in vivo systems (Schmid et al., 2006), and has been implicated in AD neuropathology (Patrick et al., 1999).